Developing a Potential Cure for Pompe Disease: Clinical Specimen Collection From Individuals With Pompe Disease
Latest Information Update: 07 May 2024
Price :
$35 *
At a glance
- Drugs Filgrastim (Primary) ; FTX-PD01 (Primary)
- Indications Glycogen storage disease type II
- Focus Therapeutic Use
- 17 May 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Mar 2023.
- 30 Sep 2021 Planned initiation date (estimated date of recruitment) changed from 1 May 2021 to 1 Feb 2022.
- 30 Sep 2021 Planned End Date changed from 31 Dec 2022 to 31 May 2023.